212 related articles for article (PubMed ID: 34071997)
1. Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization.
Pierik AS; Leemans CR; Brakenhoff RH
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071997
[TBL] [Abstract][Full Text] [Related]
2. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients.
Graveland AP; de Maaker M; Braakhuis BJ; de Bree R; Eerenstein SE; Bloemena E; Leemans CR; Brakenhoff RH
Cell Oncol; 2009; 31(4):317-28. PubMed ID: 19633367
[TBL] [Abstract][Full Text] [Related]
4. Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology.
Slootweg PJ; Hordijk GJ; Schade Y; van Es RJ; Koole R
Oral Oncol; 2002 Jul; 38(5):500-3. PubMed ID: 12110346
[TBL] [Abstract][Full Text] [Related]
5. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue.
Braakhuis BJ; Bloemena E; Leemans CR; Brakenhoff RH
Oral Oncol; 2010 Jul; 46(7):485-91. PubMed ID: 20189442
[TBL] [Abstract][Full Text] [Related]
7. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.
Tabor MP; Brakenhoff RH; Ruijter-Schippers HJ; Kummer JA; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2004 Jun; 10(11):3607-13. PubMed ID: 15173066
[TBL] [Abstract][Full Text] [Related]
8. The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection.
Höckel M; Dornhöfer N
Cancer Res; 2005 Apr; 65(8):2997-3002. PubMed ID: 15833823
[TBL] [Abstract][Full Text] [Related]
9. The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract.
Pfreundner L; Willner J; Marx A; Hoppe F; Beckmann G; Flentje M
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1287-97. PubMed ID: 10889383
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma of the forehead area: a literature review and case report.
Caldarelli C; Autorino U; Iaquinta C; De Marchi A
Oral Maxillofac Surg; 2019 Sep; 23(3):365-373. PubMed ID: 31342210
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
[TBL] [Abstract][Full Text] [Related]
12. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of minimal residual disease in head and neck cancer patients.
Graveland AP; Braakhuis BJ; Eerenstein SE; de Bree R; Bloemena E; de Maaker M; van den Brekel MW; Dijk F; Mesker WE; Tanke HJ; Leemans CR; Brakenhoff RH
Cell Oncol (Dordr); 2012 Oct; 35(5):367-75. PubMed ID: 22945509
[TBL] [Abstract][Full Text] [Related]
14.
Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
[TBL] [Abstract][Full Text] [Related]
15. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
Partridge M; Li SR; Pateromichelakis S; Francis R; Phillips E; Huang XH; Tesfa-Selase F; Langdon JD
Clin Cancer Res; 2000 Jul; 6(7):2718-25. PubMed ID: 10914716
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease in head and neck cancer.
Gath HJ; Brakenhoff RH
Cancer Metastasis Rev; 1999; 18(1):109-26. PubMed ID: 10505550
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
18. Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma.
Temam S; Casiraghi O; Lahaye JB; Bosq J; Zhou X; Julieron M; Mamelle G; Lee JJ; Mao L; Luboinski B; Benard J; Janot F
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4022-8. PubMed ID: 15217934
[TBL] [Abstract][Full Text] [Related]
19. Microscopically oriented histologic surgery for head and neck mucosal cancer.
Davidson TM; Haghighi P; Astarita R; Baird S; Seagren S
Cancer; 1987 Oct; 60(8):1856-61. PubMed ID: 3652012
[TBL] [Abstract][Full Text] [Related]
20. Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Ganci F; Allegretti M; Frascolla C; Spinella F; Rollo F; Sacconi A; Valentina P; Palcau AC; Manciocco V; Vescovo M; Cotroneo E; Blandino F; Benevolo M; Covello R; Muti P; Strano S; Vidiri A; Fontemaggi G; Pellini R; Blandino G
Biomark Res; 2024 Mar; 12(1):32. PubMed ID: 38444004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
